Filtering by:
Lung CancerFDA Approves Tecentriq (Atezolizumab) for Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has approved the immunotherapy drug Tecentriq (atezolizumab) for the treatment of small cell lung cancer (SCLC).
Lung Cancer Screening Guideline: Frequently Asked Questions
The American Cancer Society lung cancer screening guidelines recommend yearly low dose CT (LDCT) for certain people at higher risk of lung cancer that meet several conditions.
Lung Cancer Screening Guidelines for Current or Former Smokers
American Cancer Society guidelines recommend yearly lung cancer screening for people who meet certain criteria that put them at higher risk for developing the disease.
Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years
The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society.
Year in Review: Cancer Research Insights from 2018
Read highlights about American Cancer Society research from 2018.
FDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.
How to Test Your Home for Radon
Getting your home tested for radon can help protect you and your family from a key cause of lung cancer.
Lung Cancer Risks for Non-smokers
30,000 Americans are expected to die of lung cancer this year – without ever having lit a cigarette and smoked. Here’s what we know about why some non-smokers get lung cancer.